Skip to main content

View full-text article in PMC

. 2017 Dec 21;23(47):8415–8425. doi: 10.3748/wjg.v23.i47.8415

Table 2.

Basic characteristics of the studies included in the meta-analysis

Ref.	Country	Study type	Years of study	Group	Sample size	Age	Mortality	Transfusion	Rebleeding	Length of hospitalization
Boyle et al[17], 1983	United States	Retrospective	1977-1981	Control	40	54 ± 2¹	√	√	-	√
Boyle et al[17], 1983	United States	Retrospective	1977-1981	CKD (mix)	20	59 ± 4¹	√	√	-	√
Cheung et al[10], 2010	Canada	Retrospective	2000-2006	Control	50	67 ± 13	√	√	√	√
				CKD	50	71 ± 13
				ESRD	50	68 ± 12
Hung et al[25], 2014	Taiwan	Retrospective	2007	Control	6322	54.6 ± 13.3	√	-	-	-
Hung et al[25], 2014	Taiwan	Retrospective	2007	ESRD	110	NR	√	-	-	-
Sood et al[9], 2012	United States	Retrospective	2007	Control	347245	NR	√	-	-	-
				CKD	35985	NR
				ESRD	14983	NR
Tsai et al[16], 1996	Taiwan	Prospective	1991-1994	Control	640	55.7 ± 16.2²	√	√	√	-
Tsai et al[16], 1996	Taiwan	Prospective	1991-1994	ESRD	58	64.1 ± 11.4²	√	√	√	-
Zuckerman et al[26], 1985	United States	Retrospective	1980-1983	Control	423	63 (16-96)³	-	-	√	-
Zuckerman et al[26], 1985	United States	Retrospective	1980-1983	CKD (mix)	59	57 (24-84)³	-	-	√	-

¹

Data expressed as mean ± SEM (standard error of mean);

²

Data expressed as mean ± SD (standard deviation);

³

Data expressed as median (interquartile range). NR: Not reported; CKD: Chronic kidney disease; ESRD: End-stage renal disease.